Termination of Early Pregnancy in Scarred Uterus With Lletrozole and Misoprostol Compared to Misoprostol Alone
NCT ID: NCT05067309
Last Updated: 2021-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2021-10-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage
NCT03628625
Letrozole Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion
NCT04217265
Letrozole in Induction of Abortion of Anembryonic Pregnancy
NCT05198050
Use of Letrozole Pretreatment With Misoprostol for First-Trimester Medical Abortion
NCT02401425
Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages
NCT05304273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Missed abortion received letrozole then misoprostol
Letrozole 2.5mg
Missed abortion received letrozole then misoprostol
Missed abortion received misoprostol alone
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Letrozole 2.5mg
Missed abortion received letrozole then misoprostol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-viable fetus (missed abortion or blighted ovum) in the 1st trimester of pregnancy evidenced by criteria for diagnosis by TVS .
* Previous C.S or Myomectomy (1 or more )
* lack of any maternal diseases such as: heart disease, asthma, history of thromboembolism, cancer, renal failure, and liver diseases.
Exclusion Criteria
* Emergency conditions which need intervention .
* History of allergy to misoprostol or letrozole drugs.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahmed Elsayed Aref
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Elsayed Aref
Ahmed Elsayed Aref
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Elsayed Aref
Sohag, , Egypt
Ahmed Elsayed Aref
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-21-09-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.